Showing results (281-290 of 365) with videos related to
Sort By:
Pageof 37
Immunotargets and Therapy|July 4, 2017
CD8+ memory T-cell inflation renders compromised CD4+ T-cell-dependent CD8+ T-cell immunity via naïve T-cell anergyAizhang Xu, Andrew Freywald, Yufeng Xie, et al.Immunotargets and Therapy|June 21, 2018
Melanoma treatment in reviewBeatriz Domingues, José Manuel Lopes, Paula Soares, et al.Immunotargets and Therapy|November 6, 2019
Gasdermin D Hypermethylation Inhibits Pyroptosis And LPS-Induced IL-1β Release From NK92 CellsJibran Sualeh Muhammad, Manju Nidagodu Jayakumar, Noha Mousaad Elemam, et al.Immunotargets and Therapy|March 13, 2020
Immunoinformatics and Vaccine Development: An OverviewAngus Nnamdi Oli, Wilson Okechukwu Obialor, Martins Ositadimma Ifeanyichukwu, et al.Immunotargets and Therapy|March 15, 2018
Immunotherapy in Merkel cell carcinoma: role of AvelumabAmruth R Palla, Donald DollImmunotargets and Therapy|July 22, 2025
Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective StudyJiangtao Liu, Yan Wang, Li Cui, et al.Immunotargets and Therapy|October 2, 2025
Psoriasis Increases the Risk of ANCA Associated Vasculitis: Insights from A Propensity Score-Matched StudyRan Cui, Qian Wang, Zi-Jian Kang, et al.Immunotargets and Therapy|November 3, 2025
Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II StudyLicong Liang, Jingwen Zhou, Jingjun Huang, et al.Immunotargets and Therapy|November 4, 2025
Dramatic Clinical Response to a Novel Form of Cell Therapy SL-28 in a Patient with Prostate Cancer and Bone Metastasis: A Case ReportVictor Tetz, Kristina Kardava, Olzhas Shulenbayev, et al.Immunotargets and Therapy|July 1, 2025
Advancing Adjuvant Immunotherapy in Hepatocellular Carcinoma: A Comprehensive ReviewMiho Akabane, Odysseas P Chatzipanagiotou, Yuki Imaoka, et al.Pageof 37